All Stocks
K

KRYS

Krystal Biotech, Inc.
Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$260.95

Market Cap

$7.63B

Beta

0.54

P/E

38.5

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+33.95%
EPS Growth (YoY)+129.10%
Revenue CAGR 3Y+0.00%
P/E Ratio38.5
PEG Ratio0.30
FCF Yield+2.48%
Debt / Equity0.01
Interest Coverage999.0x

Sign up free to unlock full analysis

  • ✓Full 24-factor quality scorecard
  • ✓AI investment committee analysis
  • ✓Factor radar & value trap detection
  • ✓10-year strategy backtesting
  • ✓Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for KRYS.